AXIM BIOTECHNOLOGIES INC (OTCMKTS:AXIM) Can’t Be More Risky. Short Interest Increased

October 2, 2018 - By Peter Erickson

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Logo

The stock of AXIM BIOTECHNOLOGIES INC (OTCMKTS:AXIM) registered an increase of 109.32% in short interest. AXIM’s total short interest was 33,700 shares in October as published by FINRA. Its up 109.32% from 16,100 shares, reported previously. With 183,100 shares average volume, it will take short sellers 0 days to cover their AXIM’s short positions.

The stock decreased 1.68% or $0.03 during the last trading session, reaching $1.76. About 75,241 shares traded. AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) has 0.00% since October 2, 2017 and is . It has underperformed by 15.62% the S&P500.

AXIM Biotechnologies, Inc., a biotechnology company, focuses on the treatment of pain, spasticity, anxiety, and other medical disorders with the application of cannabinoids based products. The company has market cap of $102.22 million. It also focuses on the research, development, and production of pharmaceutical, nutraceutical, oral health, and cosmetic products, as well as procurement of genetically and nano-controlled active ingredients. It currently has negative earnings. The firm was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.